Hold TXN: Maintain current weight through Q3 binary catalyst; scale-in zone $250-260 with volume confirmation gate, hard stop $240
Maintain TXN at current weight with active-patience framework anchored on Q3 2026 earnings catalyst. The fundamental inflection is confirmed (Q2 FCF of $2.19B at 40.1% margin, three consecutive quarters of GM expansion from 55.9% to 58.0% to 61.4%), but 26x forward P/E at peak multiples against unconfirmed technical breakout and hostile macro (10Y at 2007 highs, 97% Polymarket no-cut probability) creates unfavorable asymmetry until Q3 confirms. Scale-in zone $250-260 requires explicit volume confirmation gate (>6M shares on any push above $278 before adding first tranche). Hard stop remains anchored at $240 (200 SMA structural floor). The optional Q3 put hedge is intellectually sound insurance against binary downside tail without capping material upside. Adding at $278 violates no-add discipline at top-of-range PE.
| Position | Action |
|---|---|
| Push above $278 on volume >6M shares with 3-day follow-through and yield regime softening | Upgrade to Overweight with measured add at $260-265 |
| Flush to $242-248 on heavy volume followed by reversal day with macro stabilization | Deep-value re-entry, upgrade to Overweight |
| Confirmed close <$258 on >5M volume with MACD line accelerating negative | Downgrade to Underweight with 15-20% trim |
| Sustained close <$250 with 50/200 SMA death cross | Expand trim to 25-30% |
| Q3 prints revenue ≥$5.5B + FCF ≥$1.8B + GM ≥60% with FY2026 FCF guide to $7B+ | Upgrade to Overweight/Buy on confirmation |
| Q3 misses on industrial/auto commentary, GM compresses below 57%, or guides down | Trim 25%, watch $260 as potential add back |
TXN is in the early innings of a multi-quarter FCF super-cycle, with the market failing to recognize the $8-9B annualized FCF run-rate versus the $3.55B TTM figure.
| Indicator | Value | Signal |
|---|---|---|
| close_50_sma | $270.72 | bullish |
| close_200_sma | $244.52 | bullish |
| close_10_ema | $269.20 | bullish |
| macd | +0.83 | bullish |
| macd_signal | -1.61 | bullish |
| macd_histogram | +2.44 | bullish |
| rsi | 60.16 | neutral |
| boll_upper | $277.04 | neutral |
| boll_middle | $263.20 | bullish |
| boll_lower | $249.35 | bullish |
| atr | $8.33 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Price pullback to $260-265 zone AND push above $278 on >6M shares volume confirmation (3-day follow-through)
Then: Add first tranche in scale-in zone
↩ rebuts: “Bear's 42x P/E argument anchoring on backward-looking TTM numbers that cannot persist”
EV: +15-25% · concedes: Today's volume was light at 3.9M shares versus 6-8M average; 42x TTM P/E is elevated (though a trap due to improving earnings); MCHP is expanding into 48V AI power market; 10-year yield at 2007 highs creates macro headwind for multiple expansion; Light volume breakout needs confirmation over next 5-10 sessions
TXN is a cyclical name priced for perfection at the precise moment the cycle is most likely to disappoint, with FCF margins artificially inflated by one-time factors and the stock vulnerable to multiple compression.
EV: -12 to -17% (bear case: $240-260) · concedes: Q2 FCF was genuinely strong in absolute terms; Dividend remains intact and is not in jeopardy; 40%+ FCF margins are achievable in the short term if CapEx discipline holds; The $30B buyback authorization exists and could be deployed if management changes posture
→ vs conservative: Trimming or bailing before Q3 misses the textbook coiled-spring entry point after a two-month base—conservative read of HOLD misreads a coiled ambush as 'wait and see'
→ vs conservative: Buyback collapse ($158M to $27M) is capex discipline and dividend prioritization, not an insider 'fair-value' signal—isolating the buyback line misses the $2.19B FCF story entirely
→ vs conservative: '26x forward P/E is peak multiple' is logically inverted—Q2 2026 was a trough quarter; 26x compresses to 16-18x on realized forward earnings, which is mid-cycle, not peak
→ vs conservative: Macro (10-year at 2007 highs, no Fed cuts) is a tailwind, not a risk—higher-for-longer rotates INTO profitable, dividend-paying, FCF-generative names like TXN with real-economy industrial/automotive insulation
→ vs conservative: 'Unconfirmed breakout' with light volume (3.9M shares) is misread—zero retail sentiment confirms institutional accumulation; institutional money doesn't telegraph; blow-off volume comes AFTER breakout, not during
→ vs conservative: 'Binary Q3 catalyst risk' is overstated—the bar is sustained margin expansion, not sequential acceleration; TXN has two consecutive quarters of operating leverage proving the thesis
| vwma | $265.24 | bullish |
| volume | 3,929,518 | bearish |
Support: 263.2 · 258 · 249.35 · 244.52 | Resistance: 277 · 278.69 · 290 · 296 · 315.83 · 329.82
TXN exhibits a predominantly bullish technical setup with all major trend indicators (10 EMA, 50 SMA, 200 SMA) rising and price above each. The MACD just completed a bullish crossover with the line crossing above zero, RSI sits at 60.16 offering room for extension before overbought territory (70), and Bollinger Bands confirm price at upper band ($277.04) indicating breakout. The ATR has compressed 39% from its July peak ($13.59) to $8.33, signaling a coiled-spring pattern resolving upward. The primary risk is the light-volume breakout (3.93M shares vs. 6-8M average), creating a yellow flag for conviction. Overall bias is bullish but unconfirmed; a follow-through session above $278 with volume ≥6M would confirm the breakout.
Market Cap
$253.95B
P/E (TTM)
42.26x
Forward P/E
26.12x
PEG Ratio
0.96
Price/Book
14.10x
EPS (TTM)
$6.58
Forward EPS
$10.64
Dividend Yield
2.25%
Beta
1.31
52-Week Range
$152.73 – $334.03
Revenue (TTM)
$19.45B
Revenue (Q2 2026)
$5.46B
Gross Margin (Q2 2026)
61.4%
Gross Margin (TTM)
58.3%
Operating Margin (Q2 2026)
42.6%
EBITDA Margin (TTM)
49%
Net Margin (TTM)
31.1%
Net Income (TTM)
$6.02B
Net Income (Q2 2026)
$1.98B
Diluted EPS (Q2 2026)
$2.14
ROE
35.2%
ROA
13.1%
Total Assets (Q2 2026)
$35.88B
Total Equity (Q2 2026)
$18.01B
Total Debt (Q2 2026)
$14.05B
Net Debt (Q2 2026)
$10.39B
Cash + ST Investments
$7.00B
Current Ratio (Q2 2026)
4.86
Debt/Equity
78.0%
Inventory (Q2 2026)
$4.61B
Net PP&E (Q2 2026)
$11.91B
Book Value per Share
$19.72
OCF (Q2 2026)
$2.70B
CapEx (Q2 2026)
$514M
FCF (Q2 2026)
$2.19B
FCF (TTM Run-rate)
$5.36B
Annual Dividends
$5.18B
Dividends per Quarter (Q2 2026)
$1.295B
Annualized Dividend per Share
$5.16
Net Debt/EBITDA
1.1x
R&D (Q2 2026)
~$510-535M
Working Capital (Q2 2026)
$12.51B
Strengths
Concerns
TXN is showing classic cyclical-recovery characteristics with elite secular quality (analog franchise, 35% ROE, dividend aristocrat). The Q2 2026 print is materially better than expectations across revenue, gross margin, operating margin, and FCF. The valuation is rich on TTM (42.26x) but reasonable on forward earnings (26.12x with PEG 0.96), and the balance sheet / dividend provide downside support. Risk/reward is balanced — favorable setup but valuation already reflects meaningful recovery.
Macro: Bond market rupture is the dominant macro theme: 10-year Treasury yield hit highest since 2007 and 30-year yield cleared highs not seen since 2004, driven by markets pricing in additional Fed rate hikes rather than cuts — a sharp regime change from the "Fed cuts into trouble" narrative. Despite this, U.S. equities finished higher, with traders characterizing the bond sell-off as "an eye-opener, not a crisis." No Fed rate cuts in 2026 carry 97% implied probability, while near-term US recession risk is low (10%) but 2027 tail risk is moderate (34%).